Vietnam Cardiac Resynchronization Therapy Market Report 2022 to 2030

Vietnam Cardiac Resynchronization Therapy Market

$ 3999

Vietnam Cardiac Resynchronization Therapy Market valued at $24 Mn in 2022, projected to reach $36 Mn by 2030 with a 5.23% CAGR. The notable increase in heart failure cases worldwide, propelled by aging demographics and lifestyle-associated cardiovascular ailments, stands as a pivotal factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, key players in this market encompass Abbott, Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Sorin Group, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Esaote.

ID: IN10VNPH443 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Dr. Medha Sansanwal

Buy Now

Vietnam Cardiac Resynchronization Therapy Market Executive Summary

Vietnam Cardiac Resynchronization Therapy Market valued at $24 Mn in 2022, projected to reach $36 Mn by 2030 with a 5.23% CAGR.

Cardiac resynchronization therapy (CRT) is a medical procedure that employs a pacemaker to correct the heart's rhythm through a minimally invasive surgical approach. Positioned beneath the skin, the CRT pacemaker synchronizes the timing between the upper and lower heart chambers, ensuring coordination between the left and right sides of the heart. This treatment is particularly beneficial for individuals with heart failure, addressing inadequate pumping and fluid retention in the lungs and legs caused by the asynchronous beating of the heart's lower chambers. In cases of severe heart rhythm irregularities, CRT therapy may be supplemented by the inclusion of an implantable cardioverter-defibrillator (ICD). The CRT device connects wires from the pacemaker to both sides of the heart, utilizing biventricular pacing to ensure synchronized contractions and optimize overall heart function.

Cardiovascular diseases (CVDs) cause 31% of deaths in Vietnam annually, totaling over 170,000 fatalities, with heart attacks as a major contributor. High-risk factors include hypertension, affecting 18.9% of adults aged 18-69, but only 13.6% receive proper management. Lifestyle choices like a 53% smoking prevalence among men, unhealthy diets leading to rising obesity rates, and increasing stress levels significantly contribute to CVD prevalence. Growing medical conditions like diabetes and moderately prevalent high blood cholesterol, along with family history, compound the cardiovascular health challenge. A comprehensive approach addressing lifestyle factors, improving healthcare management, and raising awareness of risk factors is crucial to mitigating the impact of CVDs in Vietnam and enhancing the overall population's cardiovascular health.

Recent advancements in cardiac healthcare include Abbott's Encora II pacemaker with Bluetooth connectivity, Affectis developing a surgical-free pacemaker with a $100 Mn investment from Temasek Life Sciences, and Boston Scientific's leadless pacemaker and defibrillator focusing on reduced bulk and improved comfort. Additionally, Pfizer and AstraZeneca are partnering to explore innovative pharmacological options for heart rhythm abnormalities. These advancements aim to improve patient care and offer new treatment options in cardiac healthcare.

Market Dynamics

Market Growth Drivers

Aging Population and Increased Awareness: The demographic shift towards an aging population contributes to a higher prevalence of cardiac issues. Additionally, heightened awareness among the population about heart-related disorders encourages individuals to seek timely and advanced treatments, including CRT.

Advancements in Medical Technology: Ongoing advancements in medical technology globally have a positive impact on the accessibility and effectiveness of CRT devices in Vietnam. The integration of cutting-edge technologies in cardiac care enhances treatment options and outcomes for patients.

Rising Prevalence of Cardiovascular Diseases and Heart Failure: Vietnam is witnessing a rise in the prevalence of cardiovascular diseases and heart failure, resulting in an expanding demographic of patients requiring advanced cardiac treatments such as Cardiac Resynchronization Therapy (CRT).

Market Restraints

Cost Constraints: The substantial expenses linked to Cardiac Resynchronization Therapy (CRT) devices and procedures could pose a considerable obstacle in Vietnam. The issue of affordability emerges as a prominent concern for a segment of the population, leading to restricted access to state-of-the-art cardiac care.

Regulatory Hurdles: Obstacles arise in the form of regulatory hurdles and bureaucratic procedures, posing barriers to the swift approval and entry of new CRT devices into the market. The demanding regulatory standards have the potential to impede the timely introduction of innovative technologies within the market.

Infrastructure Challenges in Rural Areas: Vietnam faces infrastructure challenges, particularly in rural areas, which can hinder the effective delivery of cardiac care, including CRT. Limited access to modern medical facilities and specialized healthcare professionals may impede market growth in these regions.

Healthcare Policies and Regulatory Landscape

In Vietnam, the Ministry of Health (MOH) and its affiliated body, the Drug Administration of Vietnam (DAV), play a central role in overseeing healthcare policies and regulatory measures related to treatment drugs. The MOH, as the principal authority, is responsible for crafting and enforcing policies that govern the approval, importation, manufacturing, and distribution of pharmaceuticals, encompassing treatment drugs. The DAV, operating under the MOH, assumes a pivotal role in managing various aspects of drug-related affairs, including registration, licensing, quality control, and product inspections. The National Pharmaceutical Control Bureau (NPCB) is tasked with conducting tests and ensuring quality assurance. The comprehensive framework is further bolstered by regulations governing clinical trials, adherence to Good Manufacturing Practice (GMP), and compliance with import and export guidelines. It is imperative to consider health insurance policies and their coverage concerning treatment drugs, underscoring Vietnam's ongoing commitment to fostering a well-regulated healthcare system that prioritizes the safety, efficacy, and accessibility of pharmaceutical treatments.

Competitive Landscape

Key Players

Abbott
Biotronik
Boston Scientific
Medtronic
St. Jude Medical
Sorin Group
Siemens Healthineers
Philips Healthcare
GE Healthcare
Esaote

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Vietnam Cardiac Resynchronization Therapy Market Segmentation

By Product

CRT-Defibrillator
CRT-Pacemaker

By Age

Below 44 years
45-64 years
65-84 years
Above 85 years

By End-Users

Hospitals
Cardiac care Centres
Ambulatory Surgical Centres

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.